Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H25NO3 |
| Molecular Weight | 315.4067 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(CCNC(=O)C23CC4CC(CC(C4)C2)C3)C=C1O
InChI
InChIKey=ZWKFENYDXISLGK-UHFFFAOYSA-N
InChI=1S/C19H25NO3/c21-16-2-1-12(8-17(16)22)3-4-20-18(23)19-9-13-5-14(10-19)7-15(6-13)11-19/h1-2,8,13-15,21-22H,3-7,9-11H2,(H,20,23)
Dopamantine is the adamantine derivative. It combined elements of both amantadine and dopamine in its structure, shares some pharmacological effects of amantadine. Dopamantine is the anti-Parkinson drug, which has passed clinical trials. Dopamantine showed a high activity against Plasmodium berghei parasites that cause malaria.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C38149
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2106204
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
7EZN745FXZ
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
100000080762
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
DTXSID70192961
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
SUB06364MIG
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
172619
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
38361
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
254-697-3
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
39907-68-1
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
C81561
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY | |||
|
3569
Created by
admin on Wed Apr 02 08:28:50 GMT 2025 , Edited by admin on Wed Apr 02 08:28:50 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
